BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 27548521)

  • 1. A liver stress-endocrine nexus promotes metabolic integrity during dietary protein dilution.
    Maida A; Zota A; Sjøberg KA; Schumacher J; Sijmonsma TP; Pfenninger A; Christensen MM; Gantert T; Fuhrmeister J; Rothermel U; Schmoll D; Heikenwälder M; Iovanna JL; Stemmer K; Kiens B; Herzig S; Rose AJ
    J Clin Invest; 2016 Sep; 126(9):3263-78. PubMed ID: 27548521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repletion of branched chain amino acids reverses mTORC1 signaling but not improved metabolism during dietary protein dilution.
    Maida A; Chan JSK; Sjøberg KA; Zota A; Schmoll D; Kiens B; Herzig S; Rose AJ
    Mol Metab; 2017 Aug; 6(8):873-881. PubMed ID: 28752051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-protein diet induces, whereas high-protein diet reduces hepatic FGF21 production in mice, but glucose and not amino acids up-regulate FGF21 in cultured hepatocytes.
    Chalvon-Demersay T; Even PC; Tomé D; Chaumontet C; Piedcoq J; Gaudichon C; Azzout-Marniche D
    J Nutr Biochem; 2016 Oct; 36():60-67. PubMed ID: 27574977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
    Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
    J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice.
    Albarazanji K; Jennis M; Cavanaugh CR; Lang W; Singh B; Lanter JC; Lenhard JM; Hornby PJ
    Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G653-G667. PubMed ID: 30920846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary protein dilution limits dyslipidemia in obesity through FGF21-driven fatty acid clearance.
    Maida A; Zota A; Vegiopoulos A; Appak-Baskoy S; Augustin HG; Heikenwalder M; Herzig S; Rose AJ
    J Nutr Biochem; 2018 Jul; 57():189-196. PubMed ID: 29751292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restriction of essential amino acids dictates the systemic metabolic response to dietary protein dilution.
    Yap YW; Rusu PM; Chan AY; Fam BC; Jungmann A; Solon-Biet SM; Barlow CK; Creek DJ; Huang C; Schittenhelm RB; Morgan B; Schmoll D; Kiens B; Piper MDW; Heikenwälder M; Simpson SJ; Bröer S; Andrikopoulos S; Müller OJ; Rose AJ
    Nat Commun; 2020 Jun; 11(1):2894. PubMed ID: 32518324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
    Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
    Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-obesity effect of FGF19 does not require UCP1-dependent thermogenesis.
    Antonellis PJ; Droz BA; Cosgrove R; O'Farrell LS; Coskun T; Perfield JW; Bauer S; Wade M; Chouinard TE; Brozinick JT; Adams AC; Samms RJ
    Mol Metab; 2019 Dec; 30():131-139. PubMed ID: 31767164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice.
    Yano K; Yamaguchi K; Seko Y; Okishio S; Ishiba H; Tochiki N; Takahashi A; Kataoka S; Okuda K; Liu Y; Fujii H; Umemura A; Moriguchi M; Okanoue T; Itoh Y
    Lab Invest; 2022 Mar; 102(3):281-289. PubMed ID: 34732847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic Aryl Hydrocarbon Receptor Attenuates Fibroblast Growth Factor 21 Expression.
    Girer NG; Murray IA; Omiecinski CJ; Perdew GH
    J Biol Chem; 2016 Jul; 291(29):15378-87. PubMed ID: 27226639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiated embryo chondrocyte 1 (DEC1) is a novel negative regulator of hepatic fibroblast growth factor 21 (FGF21) in aging mice.
    Fujita Y; Makishima M; Bhawal UK
    Biochem Biophys Res Commun; 2016 Jan; 469(3):477-82. PubMed ID: 26697751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary induction of obesity and insulin resistance is associated with changes in Fgf21 DNA methylation in liver of mice.
    Geißler C; Krause C; Neumann AM; Britsemmer JH; Taege N; Grohs M; Kaehler M; Cascorbi I; Lewis AG; Seeley RJ; Oster H; Kirchner H
    J Nutr Biochem; 2022 Feb; 100():108907. PubMed ID: 34801693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrodynamic delivery of FGF21 gene alleviates obesity and fatty liver in mice fed a high-fat diet.
    Gao M; Ma Y; Cui R; Liu D
    J Control Release; 2014 Jul; 185():1-11. PubMed ID: 24747761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary Essential Amino Acid Restriction Promotes Hyperdipsia via Hepatic FGF21.
    Rusu PM; Chan AY; Heikenwalder M; Müller OJ; Rose AJ
    Nutrients; 2021 Apr; 13(5):. PubMed ID: 33926065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice.
    Morrice N; Mcilroy GD; Tammireddy SR; Reekie J; Shearer KD; Doherty MK; Delibegović M; Whitfield PD; Mody N
    Sci Rep; 2017 Mar; 7():43782. PubMed ID: 28256636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
    Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
    Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms.
    Osataphan S; Macchi C; Singhal G; Chimene-Weiss J; Sales V; Kozuka C; Dreyfuss JM; Pan H; Tangcharoenpaisan Y; Morningstar J; Gerszten R; Patti ME
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30843877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating FGF21 in humans is potently induced by short term overfeeding of carbohydrates.
    Lundsgaard AM; Fritzen AM; Sjøberg KA; Myrmel LS; Madsen L; Wojtaszewski JFP; Richter EA; Kiens B
    Mol Metab; 2017 Jan; 6(1):22-29. PubMed ID: 28123934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-derived fibroblast growth factor 21 mediates effects of glucagon-like peptide-1 in attenuating hepatic glucose output.
    Liu J; Yang K; Yang J; Xiao W; Le Y; Yu F; Gu L; Lang S; Tian Q; Jin T; Wei R; Hong T
    EBioMedicine; 2019 Mar; 41():73-84. PubMed ID: 30827929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.